These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2315271)

  • 1. Neurochemical correlates of affective disorders and their treatment. A satellite symposium affiliated to the XVIth C.I.N.P. Congress. August 21-24, 1988.
    Pharmacol Toxicol; 1990; 66 Suppl 3():1-159. PubMed ID: 2315271
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent neurochemical and pharmacological aspects of pathogenesis and therapy of affective psychoses.
    Emrich HM; Wolf R
    Pharmacol Toxicol; 1990; 66 Suppl 3():5-12. PubMed ID: 2179931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of psychopharmacological revolutions.
    Healy D
    Psychiatr Dev; 1987; 5(4):349-76. PubMed ID: 3328200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
    Mitsushio H; Takashima M; Mataga N; Toru M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):982-9. PubMed ID: 2455042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective disorders, antidepressant drugs and brain metabolism.
    Moretti A; Gorini A; Villa RF
    Mol Psychiatry; 2003 Sep; 8(9):773-85. PubMed ID: 12931205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine in the pathogenesis of affective disorders.
    Coppen A; Wood K
    Adv Biochem Psychopharmacol; 1982; 34():249-58. PubMed ID: 6753513
    [No Abstract]   [Full Text] [Related]  

  • 8. XVIth C.I.N.P. Congress. Munich, 15th-19th August 1988. Collegium Internationale Neuro-Psychopharmacologicum. Abstracts.
    Psychopharmacology (Berl); 1988; 96 Suppl():1-427. PubMed ID: 3137633
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium.
    Kilts CD
    J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel technique to evaluate fluctuations of mood: implications for evaluating course and treatment effects in bipolar/affective disorders.
    Sree Hari Rao V; Raghvendra Rao C; Yeragani VK
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):453-66. PubMed ID: 17042883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging.
    Bauer M; London ED; Silverman DH; Rasgon N; Kirchheiner J; Whybrow PC
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S215-21. PubMed ID: 14677082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin receptor subtypes and affective disorders.
    Robinson DS
    Clin Neuropharmacol; 1993; 16 Suppl 3():S1-5. PubMed ID: 8131151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings for the 5th workshop for the Biochemical and Pharmacological Research on Affective Disorders. May 26-27, 1989, Tokyo.
    Jpn J Psychiatry Neurol; 1990 Mar; 44(1):123-57. PubMed ID: 2362387
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of zinc in the pathogenesis and treatment of affective disorders].
    Siwek MS; Wróbel A; Dudek D; Nowak G; Zieba A
    Psychiatr Pol; 2005; 39(5):899-909. PubMed ID: 16358590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-resistant affective disorders.
    Bowskill RJ; Bridges PK
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):171-2. PubMed ID: 9166385
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological treatment of adolescents with affective disorders and attention deficit disorder.
    Biederman J
    Psychopharmacol Bull; 1988; 24(1):81-7. PubMed ID: 3290952
    [No Abstract]   [Full Text] [Related]  

  • 17. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
    Hudson CJ; Young LT; Li PP; Warsh JJ
    Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative analysis of clinical drug trials for the treatment of affective disorders.
    Davis JM; Wang Z; Janicak PG
    Psychopharmacol Bull; 1993; 29(2):175-81. PubMed ID: 8290662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical mechanisms in the affective disorders and neuroendocrine correlates.
    Risch SC; Kalin NH; Murphy DL
    J Clin Psychopharmacol; 1981 Jul; 1(4):180-5. PubMed ID: 6117585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affectis Pharmaceuticals AG. Innovative drugs to treat affective disorders.
    van den Brandt S
    Arzneimittelforschung; 2005; 55(8):487-8. PubMed ID: 16149718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.